-
Orientia tsutsugamushi and RIPK3 in Necroptosis
2026-09-10
The 2025 reference study shows that Orientia tsutsugamushi lowers cellular RIPK3 abundance but does not directly disable necroptosis once the pathway is activated. Its infection, effector-expression, phosphorylation, and microscopy experiments distinguish reduction of pathway components from functional inhibition, refining models of scrub typhus pathogenesis and host-cell death.
-
Bovine Insulin for Cell Culture and Signaling
2026-09-09
Bovine insulin is more than a routine media additive: it can be used to tune proliferation, metabolism, and insulin-responsive mitochondrial biology. This workflow pairs practical formulation guidance with a neuron-focused signaling framework based on insulin, AMPK, and PINK1 regulation.
-
MRTFA-KCNMB1 Controls Cancer Cell Stiffness
2026-09-09
Gajda et al. identify potassium efflux through BK channels and the auxiliary subunit KCNMB1 as regulators of cancer-cell stiffness downstream of MRTFA. Their integrated genetic, biophysical, immune, and mouse-model experiments show that BK-channel activation stiffens tumor cells, improves cytotoxic lymphocyte killing, and reduces metastatic colonization.
-
Propranolol Rewires Burn-Related Metabolism
2026-09-08
A phase II randomized trial links propranolol’s benefits after severe burn injury to coordinated changes in adipose-tissue metabolism, lipid composition, lipolysis, and endoplasmic reticulum stress. The findings provide a mechanistic framework for studying catecholamine-driven hypermetabolism and for designing follow-up metabolic pathway experiments.
-
ETS1–SENP2 Axis in BPD Mitophagy
2026-09-08
The reference study identifies ETS1 as a transcriptional regulator that protects against bronchopulmonary dysplasia by coordinating SENP2-dependent deSUMOylation, HSPA8 recognition, and FUNDC1 degradation. Its cell and mouse findings connect mitochondrial quality control with chaperone-mediated autophagy and provide a mechanistic framework for studying excessive mitophagy in neonatal lung injury.
-
Fluorescein TSA Fluorescence System Kit Guide
2026-09-07
The Fluorescein TSA Fluorescence System Kit uses HRP-catalyzed deposition of fluorescein-labeled tyramide to amplify localized signals in fixed-cell and tissue assays. It supports sensitive fluorescence detection of low-abundance biomolecules, but its amplification chemistry does not replace target-specific antibody or probe validation.
-
Nanoparticle Uptake by Human Corneal Epithelial Cells
2026-09-05
Azadi and David examined how PLGA nanoparticle size and surface chemistry influence uptake by human corneal epithelial cells in a mucosal in vitro model. Their results identify energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, as the dominant routes and provide design guidance for topical ocular delivery systems.
-
Moxifloxacin for Reliable Cell Assays
2026-09-05
Learn how Moxifloxacin (SKU B1218) can be incorporated into cell viability, proliferation, and cytotoxicity workflows with clearer dose selection, solution preparation, and data interpretation. The article connects product-specific physicochemical data with retinal ganglion cell findings and carefully separates in vitro antibiotic toxicity research from animal metabolic observations.
-
AZD1480: A Causal Map for JAK2/STAT3
2026-09-04
AZD1480 is a potent JAK2 inhibitor for resolving how immune-derived IL-6 can sustain tumor-intrinsic STAT3 signaling. This article translates recent IDO1 research into practical assay logic, biomarker decisions, and combination-study design.
-
ATRNL1 in Atrial Fibrillation: Single-Nucleus Insights
2026-09-04
This study uses large-scale single-nucleus RNA sequencing of human left atrial tissue to identify cell-specific transcriptional changes associated with atrial fibrillation. It highlights ATRNL1 as an atrial cardiomyocyte-associated candidate linked to cellular stress responses and cardiac action-potential regulation, while also refining the interpretation of KCNN3 expression.
-
Tetracycline Workflows for Ribosome Research
2026-09-03
Tetracycline combines reversible ribosomal inhibition with practical value as an antibiotic selection marker and acute translation probe. This guide connects product handling, dose-finding, membrane-integrity controls, and insights from a lung adenocarcinoma senescence study without confusing bacterial assay evidence with cancer-treatment claims.
-
Phalloidin B7678: F-Actin Workflow Guide
2026-09-03
Phalloidin (SKU B7678) is a cyclic heptapeptide toxin used to bind and stabilize filamentous actin for endpoint cytoskeleton visualization in fixed or permeabilized samples. It is not appropriate for live-cell imaging, reversible actin-remodeling assays, or direct measurement of monomeric G-actin.
-
QX77 Molecular Chaperone Activator Workflows
2026-09-02
QX77 enables targeted interrogation of LAMP2A- and Rab11-linked chaperone-mediated autophagy in cell and stem-cell models. This workflow also shows how to compare CMA readouts with mitochondrial quality-control phenotypes without treating CMA activation as equivalent to mitophagy suppression.
-
Contextual Epinephrine Prescribing and Anaphylaxis Care
2026-09-02
The reference review challenges the assumption that every patient at risk for allergic reactions should automatically receive multiple epinephrine devices. Its central contribution is a context-sensitive prescribing framework that combines prompt treatment education, prior reaction history, severity risk, cost, access, and patient preferences.
-
MK-8745: Aurora A Inhibition in Cancer Models
2026-09-01
MK-8745 is a potent and selective Aurora A inhibitor for connecting mitotic kinase activity with genotype, apoptosis, and tumor pathology. This article develops a biomarker-aware framework for interpreting cell-cycle and xenograft responses beyond routine compound testing.